Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$581,780
-$2,293,350 QoQ
Shares Held
7,433
-83.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#370
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Derivatives in HALO

reported options exposure · as of Jun 30, 2026
CallValue
$14,832,165
CallShares
189,500
PutValue
$9,783,750
PutShares
125,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. HALO ranks #155 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in HALO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $581,780 7,433
2026-06-30 $14,832,165 189,500
2026-06-30 $9,783,750 125,000
2026-03-31 $8,712,124 134,800
2026-03-31 $2,875,130 44,486
2026-03-31 $4,045,838 62,600
2025-12-31 $8,163,490 121,300
2025-12-31 $4,152,813 61,706
2025-12-31 $14,355,090 213,300
2025-09-30 $532,815 7,265
2025-09-30 $29,174,652 397,800
2025-09-30 $19,889,808 271,200
2025-06-30 $9,489,696 182,424
2025-06-30 $6,991,488 134,400
2025-06-30 $10,341,576 198,800
2025-03-31 $10,352,853 162,245
2025-03-31 $1,563,345 24,500
2025-03-31 $10,745,604 168,400
2024-12-31 $4,523,734 94,619
2024-12-31 $11,962,062 250,200
2024-12-31 $4,986,583 104,300
2024-09-30 $5,450,793 95,227
2024-09-30 $6,782,940 118,500
2024-09-30 $4,510,512 78,800
2024-06-30 $2,419,032 46,200
2024-06-30 $3,769,920 72,000
2024-06-30 $2,003,240 38,259
2024-03-31 $2,474,686 60,833
2024-03-31 $3,710,016 91,200
2024-03-31 $1,899,756 46,700
2023-12-31 $4,143,216 112,100
2023-12-31 $1,796,256 48,600
2023-12-31 $2,994,314 81,015
2023-09-30 $4,197,644 109,886
2023-09-30 $5,401,480 141,400
2023-09-30 $1,302,620 34,100
2023-06-30 $4,234,977 117,410
2023-06-30 $4,891,092 135,600
2023-06-30 $3,376,152 93,600
2023-03-31 $6,218,324 162,826
2023-03-31 $6,435,015 168,500
2023-03-31 $1,833,120 48,000
2022-12-31 $2,002,880 35,200
2022-12-31 $10,355,800 182,000
2022-12-31 $5,317,760 93,458
2022-09-30 $6,948,877 175,743
2022-09-30 $1,759,530 44,500
2022-09-30 $6,274,998 158,700
2022-06-30 $4,238,564 96,331
2022-06-30 $3,982,000 90,500